Subsequently, a novel CD8+ T cell-associated prognostic model was developed by univariate Cox regression and LASSO regression analyses for ovarian cancer patients in TCGA cohort, and further validated in other independent cohorts from the GEO dataset. This evidence concerns the gene CD8A and ovarian carcinoma.